TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
**see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling, government shutdown, Continuing Resolution H.J.Res. 59, Continuing Appropriations Resolution, 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Health Issues HCR
**see addendum pagePL 111-148 - The Patient Protection and Affordable Care Act, implementation FDA User Fee Reauthorizations, drug development policies, accelerated approval PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation S. 10, S. 954 - Agriculture Reform, Food, and Jobs Act of 2013 H.R. 2186 - Valid Compounding Act H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace S. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace ***, no specific bill, Raising Awareness of Hepatitis C, HHS National Strategy, Raising Awareness of Cystic Fibrosis ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening guidelines, PDUFA, federal flu policy, Sunshine, Orphan drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.